MiMedx Group (MDXG) Metrics: History & Chart

MiMedx Group, Inc.(MDXG)

Biotechnology · Marietta, GA

$4.60+0.05 (+1.00%)

Delayed quote: Oct 6, 2026, 11:55 AM EDT

About MiMedx Group, Inc.

MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to treat human placental tissues, a method crucial for manufacturing allografts that preserve the natural biological characteristics and essential regulatory proteins of the original tissue. This exclusive and patented processing technique incorporates both aseptic procedures and a final sterilization step, ensuring product safety and efficacy. Among its offerings is EpiFix, a semi-permeable membrane designed to act as a protective barrier, effectively treating persistent wounds such as diabetic foot ulcers, venous leg ulcers, and pressure sores. Another key product is AmnioFix, a protective, semi-permeable allograft made from dehydrated human amnion/chorion membrane, utilized to aid post-surgical recovery. EpiCord and AmnioCord, both derived from dehydrated human umbilical cord, function as allografts that foster a protective healing environment and are applied in both advanced wound care and surgical recovery contexts. AMNIOBURN is also a semi-permeable protective allograft specifically developed for managing partial and full-thickness burn injuries. Its flagship product, mdHACM, is a micronized, powdered version of AMNIOFIX. These products predominantly find use in healthcare sectors like wound management, burn treatment, surgical procedures, and non-operative sports medicine. Additionally, the company supplies allografts for dental uses to other manufacturers on an original equipment manufacturer (OEM) basis. Distribution of its products primarily occurs within the United States, facilitated by its own sales teams, independent agents, and various independent distributors. MiMedx Group, Inc.'s main office is located in Marietta, Georgia.

Marietta, GA

808 employees

www.mimedx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Joseph H. Capper

View full financials

Third-Party DCF Estimate (FMP)	$3.61
Price Gap vs Third-Party Estimate	-21.53%

7D Total Return	-2.78%
30D Total Return	-0.44%
YTD Total Return	-32.79%
1Y Total Return	-36.89%
3Y Total Return	-39.82%
5Y Total Return	-22.37%
10Y Total Return	-48.71%
15Y Total Return	+313.78%
20Y Total Return	N/A

2026	-32.79%
2025	-29.63%
2024	+9.69%
2023	+215.47%
2022	-53.97%
2021	-33.48%
2020

CAGR TTM	-36.75%
CAGR 3Y	-15.57%
CAGR 5Y	-4.94%
CAGR 10Y	-6.46%
CAGR 15Y	+9.93%
CAGR 20Y	N/A

PE Ratio	113.75
PE Ratio Avg TTM	20.20
PE Ratio Avg 3Y	19.74
Current VS TTM Avg	+463.07%
Current VS 3Y Avg	+476.28%
Current VS 5Y Avg	+476.28%

All Metrics

MDXG Valuation Metrics

MDXG Stock Price Metrics

MDXG Dividend Metrics

MDXG Growth Rate Metrics

MDXG Discounted Cash Flow Metrics

MDXG Returns By Period

MDXG Yearly Returns

MDXG Average Annual Returns By Period (CAGR)

MDXG Revenue Metrics

MDXG PE Ratio Metrics

MDXG PS Ratio Metrics

MDXG PB Ratio Metrics

MDXG Price to Free Cash Flow Ratio Metrics

MDXG Debt to Equity Ratio Metrics

MDXG PEG Ratio Metrics

MDXG FCF Yield

MDXG Earnings Yield

MDXG EBITDA Yield

MDXG OCF Yield

MDXG EV/EBIT Ratio Metrics

MDXG EV/EBITDA Ratio Metrics

MDXG EV/Assets Ratio Metrics

MDXG EV/Sales Ratio Metrics

MDXG Current Ratio Metrics

MDXG Quick Ratio Metrics

MDXG ROIC Metrics

MDXG Return on Assets Metrics

MDXG Return on Equity Metrics

MDXG Net Profit Margin Metrics

MDXG Gross Profit Margin Metrics

MDXG Tax Rate Metrics

PS Ratio	1.89
PS Ratio Avg TTM	1.93
PS Ratio Avg 3Y	2.72
Current VS TTM Avg	-2.26%
Current VS 3Y Avg	-30.59%
Current VS 5Y Avg	-22.95%

PB Ratio	3.11
PB Ratio Avg TTM	3.17
PB Ratio Avg 3Y	4.99
Current VS TTM Avg	-1.89%
Current VS 3Y Avg	-37.64%
Current VS 5Y Avg	-37.64%

PFCF Ratio	16.57
PFCF Ratio Avg TTM	12.94
PFCF Ratio Avg 3Y	21.36
Current VS TTM Avg	+28.04%
Current VS 3Y Avg	-22.42%
Current VS 5Y Avg	-22.42%

Debt/Equity Ratio	0.01
Debt/Equity Ratio Avg TTM	0.07
Debt/Equity Ratio Avg 3Y	0.10
Current VS TTM Avg	-89.43%
Current VS 3Y Avg	-92.95%
Current VS 5Y Avg	-97.98%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	6.03%
FCF Yield Avg TTM	8.57%
FCF Yield Avg 3Y	4.62%
Current VS TTM Avg	-29.64%
Current VS 3Y Avg	+30.53%
Current VS 5Y Avg	+30.53%

Earnings Yield	0.88%
Earnings Yield Avg TTM	4.34%
Earnings Yield Avg 3Y	4.76%
Current VS TTM Avg	-79.74%
Current VS 3Y Avg	-81.50%
Current VS 5Y Avg	-81.50%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	61.49
Ev/Ebit Ratio Avg TTM	12.73
Ev/Ebit Ratio Avg 3Y	17.53
Current VS TTM Avg	+382.92%
Current VS 3Y Avg	+250.86%
Current VS 5Y Avg	+207.69%

Ev/Ebitda Ratio	26.37
Ev/Ebitda Ratio Avg TTM	12.95
Ev/Ebitda Ratio Avg 3Y	17.11
Current VS TTM Avg	+103.66%
Current VS 3Y Avg	+54.10%
Current VS 5Y Avg	+48.16%

Ev/Assets Ratio	1.92
Ev/Assets Ratio Avg TTM	1.98
Ev/Assets Ratio Avg 3Y	3.48
Current VS TTM Avg	-3.05%
Current VS 3Y Avg	-44.87%
Current VS 5Y Avg	-41.49%

Ev/Sales Ratio	1.52
Ev/Sales Ratio Avg TTM	1.59
Ev/Sales Ratio Avg 3Y	2.50
Current VS TTM Avg	-4.52%
Current VS 3Y Avg	-39.10%
Current VS 5Y Avg	-33.34%

Current Ratio	5.33
Current Ratio Avg TTM	4.77
Current Ratio Avg 3Y	4.18
Current VS TTM Avg	+11.86%
Current VS 3Y Avg	+27.76%
Current VS 5Y Avg	+38.96%

Quick Ratio	4.79
Quick Ratio Avg TTM	4.27
Quick Ratio Avg 3Y	3.67
Current VS TTM Avg	+12.13%
Current VS 3Y Avg	+30.69%
Current VS 5Y Avg	+40.57%

ROIC	1.97%
ROIC Avg 3Y	15.79%
ROIC Avg 5Y	5.28%
Current VS 3Y Avg	-87.51%
Current VS 5Y Avg	-62.67%
Current VS 10Y Avg	+14984.96%

ROA	2.22%
ROA Avg TTM	0.84%
ROA Avg 3Y	3.45%
Current VS TTM Avg	+165.07%
Current VS 3Y Avg	-35.74%
Current VS 5Y Avg	+431.97%

ROE	2.89%
ROE Avg TTM	13.28%
ROE Avg 3Y	23.46%
Current VS TTM Avg	-78.24%
Current VS 3Y Avg	-87.68%
Current VS 5Y Avg	+95.87%

Net Profit Margin	1.76%
Net Profit Margin Avg TTM	(0.82%)
Net Profit Margin Avg 3Y	10.60%
Current VS TTM Avg	+313.38%
Current VS 3Y Avg	-83.40%
Current VS 5Y Avg	+370.05%

Gross Profit Margin	78.85%
Gross Pft Margin Avg TTM	77.59%
Gross Pft Margin Avg 3Y	82.70%
Current VS TTM Avg	+1.62%
Current VS 3Y Avg	-4.65%
Current VS 5Y Avg	-4.56%

Tax Rate	30.31%
Tax Rate Avg 3Y	(4.74%)
Tax Rate Avg 5Y	19.22%
Current VS 3Y Avg	+739.92%
Current VS 5Y Avg	+57.68%
Current VS 10Y Avg	+144.22%